Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Pharma
Legend Biotech, Taiho-Cullinan, WuXi AppTec—Fierce Pharma Asia
Legend Biotech posted its first profit. Taiho and Cullinan's EGFR drug scored a phase 3 win. WuXi AppTec won round 1 in its lawsuit against DOD.
Angus Liu
Aug 14, 2026 8:52am
AbbVie’s Skyrizi leading drug in pharma’s ad spending league
Aug 7, 2026 9:45am
With $5.5B sales, AbbVie's Skyrizi matches Humira's best quarter
Jul 31, 2026 11:18am
Sarepta taps AbbVie vet Severino to take over for retiring CEO
Jul 27, 2026 11:36am
J&J’s Tremfya remains on top in Q2 pharma ad spending league
Jul 21, 2026 9:10am
J&J’s Tremfya retakes ad spending top spot in June
Jul 10, 2026 7:24am
